New Delhi, June 15, 2026 — The Association of Indian Medical Device Industry (AiMeD) warmly welcomes the Haryana Pharmaceutical and Medical Devices Manufacturing Policy 2026, calling it possibly the most incentivising and progressive framework announced by any state in India. This policy is not just
New Delhi, June 05, 2026 — The National Medical Commission’s (NMC) recent advisory mandating strict adherence to safe injection practices is not just another compliance circular. It is a direct response to preventable outbreaks of HIV, Hepatitis B (HBV), and Hepatitis C (HCV) caused by
“Poised for Takeoff: MedTech in India” report launched at the national policy platform attended by over 450 delegates and 70+ eminent speakers from government, industry, research institutions, and healthcare ecosystems The 3rd Edition of MedTech Policy Mahotsav 2026, organized by Global MedTech Advocacy & Advisory Forum
New Delhi: Mr. Rajiv Nath, senior industry leader and key voice of India’s manufacturing and export ecosystem, has congratulated the Hon’ble Prime Minister Shri Narendra Modi and the Government of India on the successful signing of the India–Oman Comprehensive Economic Partnership Agreement (CEPA), calling it
Visakhapatnam, December 11–13: The Andhra Pradesh MedTech Zone (AMTZ) successfully hosted the three-day World Health Innovation Forum from December 11 to 13, drawing strong participation from healthcare and MedTech leaders across Asia, Europe, and African countries, alongside senior stakeholders from across India. The forum served as
Delhi, November 14th, 2025: A seven-member delegation representing India’s medical devices industry was invited to a high-level Roundtable at the House of Lords in the UK Parliament to deliberate on emerging opportunities under the ongoing Comprehensive Economic and Trade Agreement (CETA). The session, jointly organised
New Delhi, October 10, 2025: The Association of Indian Medical Device Industry (AiMeD) has welcomed the Government of India’s latest step to speed up GST refunds for exporters and manufacturers. The new system, announced by the Central Board of Indirect Taxes and Customs (CBIC), allows 90%
India’s healthcare stakeholders — including hospitals, diagnostic chains, medical device firms, insurers and pharma groups — have responded positively to the rollout of GST 2.0, saying the tax changes announced under Prime Minister Narendra Modi’s leadership will alleviate cost pressures, expand access, and give a
Indian manufacturers urge for stricter scrutiny, citing data privacy, quality, and national security concerns India’s domestic medical technology (MedTech) manufacturers have raised serious alarms regarding the increasing penetration of Chinese medical devices in the Indian healthcare ecosystem, flagging major concerns about national security, data privacy, and
In what can only be described as a transformative turning point for India’s medical technology sector, India Health 2025, hosted by Informa Markets at Pragati Maidan, New Delhi, has emerged as more than just a healthcare exhibition — it is a testament to India's medtech
